Susanne Brix Pedersen 

Professor, DTU Bioengineering

Email: sbrix@dtu.dk

Susanne Brix Pedersen is a Professor at DTU Bioengineering and Head of Section for Medical Biotechnology specializing in disease systems immunology. Her research focuses on host-microbiota interactions in lifestyle-related diseases such as allergy, asthma, inflammatory bowel diseases, obesity-related disorders, and functional somatic disorders to uncover underlying disease pathways. A key interest is the early-life programming of immune functions and the gut-brain axis, with an emphasis on immune regulation at barrier sites like the gut and lungs.
Her research group utilizes and develops multi-faceted technologies, including high-throughput single-cell analysis, metagenomics, functional assays and antibody-coating methods to study disease pathways via immune deregulation in the mucosa, body fluids and tissues. Combining experimental models, clinical studies, and systems biology, her research deciphers immunoregulatory effects of microbes and microbial metabolites in health and disease. Recent breakthroughs include the identification of non-antibody coated gut pathobionts in severe Crohn’s disease, and discovery of an early life gut bacterial metabolite that modify IgE responses, and link to reduced allergic disease development during childhood.

DTU Bioengineering

The Department of Biotechnology and Biomedicine (DTU Bioengineering) is an international leader in biotechnology and biomedicine committed to engineering the molecules of life for a sustainable and healthy future. With an engineering-driven approach, the department brings unique expertise to the growing bio-based economy and the transformation of health systems toward personalized medicine.  DTU Bioengineering's mission is to advance knowledge and technology for understanding biological and molecular systems, contributing to sustainable bioprocesses and improved human and planetary health.
The department addresses societal and scientific challenges through research, education, and innovation in microbiology, biomedicine, nanotechnology, and biotechnology. Key research sections include Medical Biotechnology, Microbial and Chemical Ecology, Synthetic Biology, and Protein Chemistry and Enzyme Technology.
Secondary Metabolites (CeMiSt), further driving innovation and supporting the UN Sustainable Development Goals. Research at DTU Bioengineering is supported by seven highly specialized research infrastructure facilities and a research data hub.